DK3091973T3 - Lipidsammensætning til forbedring af kropssammensætningen under indhentning af vækst - Google Patents

Lipidsammensætning til forbedring af kropssammensætningen under indhentning af vækst Download PDF

Info

Publication number
DK3091973T3
DK3091973T3 DK14796306.0T DK14796306T DK3091973T3 DK 3091973 T3 DK3091973 T3 DK 3091973T3 DK 14796306 T DK14796306 T DK 14796306T DK 3091973 T3 DK3091973 T3 DK 3091973T3
Authority
DK
Denmark
Prior art keywords
lipid
infants
nutritional composition
growth
infant
Prior art date
Application number
DK14796306.0T
Other languages
English (en)
Inventor
Der Beek Eline Marleen Van
Marieke Abrahamse-Berkeveld
Inga Christiane Teller
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK3091973T3 publication Critical patent/DK3091973T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (13)

1. Ernæringssammensætning omfattende lipid, hvor lipiden forekommer i lipid-globuliner, som har: (a) en volumenvægtet modusdiameter på mindst 1,0 pm; og (b) en phospholipidcoating, hvor ernæringssammensætningen omfatter mindst 0,5 vægt-% phospholipider baseret på den samlede mængde lipid, og hvor ernæringssammensætningen yderligere omfatter 2,1 til 4,1 g protein pr. 100 kcal og 1,7 til 3,3 g protein pr. 100 ml, til anvendelse til forbedring af fordelingen affedtvæv hos et spædbarn udvalgt fra gruppen bestående af for tidligt fødte børn, spædbørn, der er små i forhold til deres gestationsalder, og spædbørn med hæmmet vækst som følge af fysisk eller mental stress efter fødslen.
2. Ernæringssammensætning til anvendelse ifølge krav 1, hvor forbedring af fordelingen af fedtvæv forekommer under eller direkte efter indhentning af vækst.
3. Ernæringssammensætning til anvendelse ifølge krav 1 eller 2, hvor lipid-globulinerne har en volumenvægtet modusdiameter på mindst 1,0 pm, fortrinsvis en volumenvægtet modusdiameter på 3,0 til 8,0 pm.
4. Ernæringssammensætning til anvendelse ifølge et hvilket som helst af kravene 1 til 3, hvor phospholipiderne stammer fra mælk.
5. Ernæringssammensætning til anvendelse ifølge et hvilket som helst af kravene 1 til 4, hvor spædbarnet er et spædbarn, der er lille i forhold til sin gestationsalder.
6. Ernæringssammensætning til anvendelse ifølge krav 5, hvor spædbarnet, der er lille i forhold til sin gestationsalder, er et spædbarn med begrænset intrauterin vækst.
7. Ernæringssammensætning til anvendelse ifølge et hvilket som helst af kravene 1 til 6, hvor ernæringssammensætningen omfatter 0,3 til 0,7 vægt-% ara-chidonsyre, baseret på den samlede mængde lipid.
8. Modermælkserstatning udvalgt blandt en formulering til for tidligt fødte børn, en formulering til børn med lav fødselsvægt eller en pædiatrisk formulering til indhentning afvækst, omfattende protein, kulhydrater og lipid, hvor: (i) energitætheden er 50 til 200 kcal pr. 100 ml; (ii) lipid forekommer med 4,4 til 6,0 g pr. 100 kcal; (iii) protein forekommer med 2,1 til 4,1 g pr. 100 kcal, og med 1,7 til 3,3 g pr. 100 ml; (iv) kulhydrater forekommer med 10 til 12 g pr. 100 kcal, (v) lipid forekommer i lipidglobuliner, som har: (a) en volumenvægtet modusdiameter på mindst 1,0 pm; og (b) en phospholipidcoating, hvor sammensætningen omfatter mindst 0,5 vægt-% phospholipider baseret på den samlede mængde lipid.
9. Modermælkserstatning ifølge krav 8, som er en formulering til for tidligt fødte børn eller en formulering til børn med lav fødselsvægt, omfattende 2,6 til 3,4 g protein pr. 100 kcal og 1,7 til 3,1 g protein pr. 100 ml.
10. Modermælkserstatning ifølge krav 8, som er en pædiatrisk formulering til indhentning afvækst, omfattende 2,4 til 2,8 g protein pr. 100 kcal og 1,7 til 3,1 g protein pr. 100 ml.
11. Modermælkserstatning ifølge et hvilket som helst af kravene 8 til 10, omfattende 0,3 til 0,7 vægt-% arachidonsyre, baseret på den samlede mængde lipid.
12. Modermælkserstatning ifølge et hvilket som helst af kravene 8 til 11, omfattende 0,3 til 0,5 vægt-% docosahexaensyre, baseret på den samlede mængde lipid.
13. Ikke-terapeutisk fremgangsmåde til tilvejebringelse af ernæring til et spædbarn udvalgt fra gruppen bestående af for tidligt fødte børn, spædbørn, der er små i forhold til deres gestationsalder, og spædbørn med hæmmet vækst som følge af fysisk eller mental stress efter fødslen, omfattende indgivelse af ernæringssammensætningen ifølge et hvilket som helst af kravene 8 til 12 til spædbarnet.
DK14796306.0T 2013-11-01 2014-11-03 Lipidsammensætning til forbedring af kropssammensætningen under indhentning af vækst DK3091973T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13191300 2013-11-01
PCT/NL2014/050761 WO2015065193A1 (en) 2013-11-01 2014-11-03 Lipid composition for improving body composition during catch-up growth

Publications (1)

Publication Number Publication Date
DK3091973T3 true DK3091973T3 (da) 2018-11-05

Family

ID=49510081

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14796306.0T DK3091973T3 (da) 2013-11-01 2014-11-03 Lipidsammensætning til forbedring af kropssammensætningen under indhentning af vækst

Country Status (12)

Country Link
US (2) US20160263033A1 (da)
EP (2) EP3466277A1 (da)
CN (1) CN105873458B (da)
BR (1) BR112016009351B1 (da)
DK (1) DK3091973T3 (da)
ES (1) ES2693519T3 (da)
PL (1) PL3091973T3 (da)
PT (1) PT3091973T (da)
RU (1) RU2662282C2 (da)
SI (1) SI3091973T1 (da)
TR (1) TR201816481T4 (da)
WO (1) WO2015065193A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
DK3091973T3 (da) 2013-11-01 2018-11-05 Nutricia Nv Lipidsammensætning til forbedring af kropssammensætningen under indhentning af vækst
ES2964285T3 (es) 2015-10-15 2024-04-05 Nutricia Nv Fórmula para lactantes con grasa láctea para promover un crecimiento saludable
PL3574771T3 (pl) 2015-10-15 2023-03-13 N.V. Nutricia Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu
BR112019011809B1 (pt) 2016-12-09 2023-02-28 N.V. Nutricia Uso de lipídeo na forma de glóbulos lipídicos
CN110662433B (zh) * 2017-03-29 2024-08-02 N·V·努特里奇亚 用于改善的饮食行为的婴儿配方物
RU2761114C2 (ru) * 2017-03-29 2021-12-06 Н.В. Нютрисиа Детская смесь для улучшения пищевого поведения
RU2698294C1 (ru) * 2019-05-13 2019-08-23 Наталья Владимировна Коротаева Способ определения дистрессового состояния внутриутробного периода на основании оценки двигательных дескрипторов
US20220386672A1 (en) 2019-12-05 2022-12-08 N.V. Nutricia Infant formula with special lipid architecture for improving postnatal growth of infants born to overweight and obese mothers
PL4068991T3 (pl) 2019-12-05 2024-09-02 N.V. Nutricia Mieszanka do żywienia niemowląt, o specjalnej strukturze lipidowej, poprawiająca wzrost niemowląt, po narodzinach urodzonych przez cesarskie cięcie
AU2021212325A1 (en) * 2020-01-31 2022-07-28 N.V. Nutricia Nutritional composition for use in gut maturation
CN115190765A (zh) * 2020-02-27 2022-10-14 雅培制药有限公司 改进骨健康的方法
WO2026033137A1 (en) 2024-08-08 2026-02-12 N.V. Nutricia Particulate nutritional composition with large lipid globules
WO2026033138A1 (en) 2024-08-09 2026-02-12 N.V. Nutricia Nutritional composition with large lipid globules and native protein

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1084006A1 (ru) 1981-11-09 1984-04-07 Казахский Филиал Института Питания Амн Ссср Способ приготовлени пищевой эмульсии
NL8800629A (nl) 1988-03-15 1989-10-02 Ver Coop Melkind Gesproeidroogd melkpoederprodukt en werkwijze voor de bereiding daarvan.
ES2033193B1 (es) 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
IL119982A (en) 1997-01-09 2000-07-26 Shapira Niva Bottle for infant feeding
CN1191828C (zh) 1997-03-27 2005-03-09 布里斯托尔-迈尔斯斯奎布公司 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
JP2001158736A (ja) 1999-11-30 2001-06-12 Snow Brand Milk Prod Co Ltd 骨関節疾患の予防及び改善剤
US6596302B2 (en) 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
US7090862B2 (en) 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
US6620427B2 (en) 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
AU2002320407A1 (en) 2001-07-10 2003-01-29 Trustees Of Boston University Modified-fat nutritional products useful for preventing or treating obesity
US6902739B2 (en) 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
IL150240A (en) 2002-06-16 2005-07-25 Lipogen Ltd Infant formula supplemented with phospholipids
JP4446962B2 (ja) 2003-07-16 2010-04-07 出光興産株式会社 樹脂材料への超音波振動付与装置、この超音波振動付与装置を用いた樹脂材料の溶融成形方法及び樹脂組成物
JP2007501241A (ja) 2003-08-06 2007-01-25 ローディア インコーポレイティド 骨成長を促進する方法
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
WO2005051092A2 (en) 2003-11-20 2005-06-09 Alteragon Pty Ltd Method of decreasing fat deposits and body weight in mammals and birds
US9040075B2 (en) 2003-12-19 2015-05-26 Abbott Laboratories Method of increasing lean body mass and reducing body fat mass in infants
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1811867A2 (en) 2004-11-12 2007-08-01 N.V. Nutricia Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
DK1858342T3 (da) 2005-03-08 2009-08-24 Nestec Sa Fremgangsmåde til fremstilling af ernæringssammensætninger
US20060210697A1 (en) 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
CN101166428B (zh) 2005-04-27 2015-03-04 努特里希亚公司 含脂类和不易消化的糖的营养品
EP1898722B1 (en) 2005-04-28 2013-04-10 Enzymotec Ltd. Polar lipid mixtures, their preparation and uses
TWI282268B (en) 2005-09-15 2007-06-11 Univ Chung Shan Medical Medical image system and method for measuring vertebral axial rotation
US7311676B2 (en) 2005-09-23 2007-12-25 Park Sangdo Portable non-invasive device for measuring the hardness of muscle or muscle compartment
WO2007039596A1 (en) 2005-10-05 2007-04-12 Nestec S.A. Nutritional formulation for promoting catch-up growth
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
BRPI0620465A2 (pt) 2005-12-23 2011-11-16 Nutricia Nv uso de uma composição
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
KR100598607B1 (ko) 2006-02-24 2006-07-07 주식회사 일신웰스 유지 조성물 및 이의 제조방법
ATE524073T1 (de) * 2006-03-27 2011-09-15 Nestec Sa Molkenprotein micellen
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
KR20090097945A (ko) 2006-12-28 2009-09-16 메이지 데어리즈 코포레이션 젖 유래 인지질을 함유하는 유유아 뇌발달 촉진제 및 그것을 함유하는 식품 조성물
WO2009051502A1 (en) 2007-10-19 2009-04-23 Steven Charles Hodgkinson Methods of maintaining or increasing growth or cognitive development
US8975299B2 (en) 2007-11-01 2015-03-10 Enzymotec Ltd. Lipid mixture for infant nutrition
EP2221057A4 (en) 2007-11-19 2014-04-09 Megmilk Snow Brand Co Ltd MEANS FOR IMPROVING THE SENSES
FR2930406B1 (fr) 2008-04-29 2011-04-15 Groupe Lactalis Aliment infantile a base de matiere grasse d'origine laitiere
BRPI0915337B1 (pt) 2008-06-16 2019-09-24 N.V. Nutricia Uso de gordura vegetal, proteína e carboidrato e da fórmula líquida de leite para bebê, recipiente contendo uma fórmula líquida de leite para bebê, processo para preparar uma fórmula líquida de leite para bebê, uso da fórmula líquida de leite para bebê, fórmula líquida de leite para bebê e pó
WO2010027259A1 (en) 2008-09-02 2010-03-11 N.V. Nutricia Nutritional compositions with coated lipid globules
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
WO2010070613A2 (en) 2008-12-18 2010-06-24 University College London Baby feeding formula and system
EP2216036A1 (en) 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
KR101050429B1 (ko) 2009-03-18 2011-07-19 연세대학교 산학협력단 캠펜을 유효성분으로 포함하는 비만, 이상지방혈증, 지방간또는 인슐린 저항성 증후군의 예방 또는 치료용 조성물
WO2010134800A1 (en) * 2009-05-19 2010-11-25 N.V. Nutricia Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution
MX355042B (es) 2009-06-08 2018-04-02 Acceleon Pharma Inc Metodos para aumentar adipositos termogenicos.
WO2011071367A1 (en) 2009-12-11 2011-06-16 N.V. Nutricia Metabolic imprinting effects of structured lipids
WO2011108918A1 (en) * 2010-03-04 2011-09-09 N.V. Nutricia Modulation of post-prandial fat absorption
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
EP3181692A1 (en) 2010-05-07 2017-06-21 Centre National De La Recherche Scientifique Ucp1 (thermogenin) - inducing agents for use in the treatment of a disorder of the energy homeostasis
EP2465359A1 (en) 2010-12-15 2012-06-20 Nestec S.A. Improved nutritional composition, especially for infants, with particular fat particles
WO2012173467A1 (en) * 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
AU2012287155A1 (en) 2011-07-22 2014-01-30 Nestec S.A. Methods for reducing childhood obesity
WO2013036103A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Use of infant formula with large lipid globules
WO2013036104A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Infant nutrition for regulating food intake later in life
WO2013036102A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Use of infant formula with cholesterol
EP2583562A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for infants at risk of obesity or diabetes
EP2638810A1 (en) 2012-03-15 2013-09-18 N.V. Nutricia Process for preparing infant formula
EP2638811A1 (en) 2012-03-15 2013-09-18 N.V. Nutricia Process for preparing infant formula
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
NZ716341A (en) 2013-08-01 2018-02-23 Loders Croklaan Bv Glyceride composition
DK3091973T3 (da) 2013-11-01 2018-11-05 Nutricia Nv Lipidsammensætning til forbedring af kropssammensætningen under indhentning af vækst
WO2015067325A1 (en) 2013-11-11 2015-05-14 N.V. Nutricia Powdered nutritional composition with large lipid globules
ES2729757T3 (es) 2013-11-29 2019-11-06 Nestle Sa Uso de composiciones nutritivas que tienen un reducido contenido de proteínas
US20170000810A1 (en) 2013-12-19 2017-01-05 Nestec S.A. Nutritional composition to reduce metabolic stress in infants
US20160015068A1 (en) 2014-07-16 2016-01-21 Mead Johnson Nutrition Company Nutritional formulas containing oil blends and uses thereof
WO2016024864A1 (en) 2014-08-15 2016-02-18 N.V. Nutricia Lipid composition for improving behaviour
PL3574771T3 (pl) 2015-10-15 2023-03-13 N.V. Nutricia Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu

Also Published As

Publication number Publication date
RU2662282C2 (ru) 2018-07-25
CN105873458A (zh) 2016-08-17
TR201816481T4 (tr) 2018-11-21
US11376222B2 (en) 2022-07-05
PL3091973T3 (pl) 2019-01-31
CN105873458B (zh) 2024-11-15
US20160263033A1 (en) 2016-09-15
SI3091973T1 (sl) 2018-10-30
WO2015065193A1 (en) 2015-05-07
EP3091973B1 (en) 2018-08-15
NZ719159A (en) 2021-03-26
PT3091973T (pt) 2018-11-15
EP3091973A1 (en) 2016-11-16
BR112016009351B1 (pt) 2020-12-22
US20200306189A1 (en) 2020-10-01
RU2016121411A (ru) 2017-12-04
RU2016121411A3 (da) 2018-05-21
ES2693519T3 (es) 2018-12-12
EP3466277A1 (en) 2019-04-10

Similar Documents

Publication Publication Date Title
US11376222B2 (en) Lipid composition for improving body composition during catch-up growth
EP2341784B1 (en) Nutritional compositions with coated lipid globules
EP2358438B1 (en) Nutritional compositions with large lipid globule size
AU2013277900B2 (en) Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
EP3167726B1 (en) Modulation of post-prandial fat absorption
CN103763941A (zh) 专门设计的脂质组分的代谢印记效应
NZ719159B2 (en) Lipid composition for improving body composition during catch-up growth